ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Rall, FDA Chief On AACR Panel

April 27, 1979

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

In Brief: Minna to Leave NCI For Texas Southwestern; Alexander Is Special Populations Branch Chief

February 22, 1991

In Brief: Kessler Urges Cardiologists To Fight Teen Smoking; ODAC To Meet Dec. 14

December 1, 1995

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013